EFFECT OF PLASMA ANGIOTENSIN CONVERTING ENZYM IN ERECTILE DYSFUNCTION
##plugins.themes.bootstrap3.article.main##
##plugins.themes.bootstrap3.article.sidebar##
Abstract
Objective:The aim of this study was to know the effect of aging and I/D angiotensin converting enzymes (ACE) gene polymorphisms in modulating plasma ACE level in erectile dysfunction(ED) subjects.Material & method:This case control study carried out in Makassar with 83 male subjects (49 ED subjects and 34 normal subjects). International Index of Erectile Function-5 was used for ED diagnosis while plasma ACE level and genotyping ACE gene examined with ELISA test and Rigat PCR method respectively.Results:The data showed that plasma ACE level siginificantly higher in ED group compared to normal group, while the plasma ACE level consistently raised following the increased of age in ED group but did not statistically significant (p>0.05) compare to normal group. DD genotype in ED group had mean plasma ACE higher compared to ID and II subjects eventhough did not statistically significant.Conclusion: The high level of ACE plasma appeared to have a pivotal rule in ED mechanisms as well as in older ED subjects. DD genotype partly modulated the raising of plasma ACE in ED subject comprared to ID and II genotype. Keywords: Plasma ACE level, erectile dysfunction.
##plugins.themes.bootstrap3.article.details##
Cohan P, Korenman SG. Erectile dysfunction. J Clin Endocr Metabol. 2001; 86: 2391-4.
Yang R, Yang B, Wen Y, Fang F, Cui S, Lin G, et al. Losartan, an Angiotensin type I receptor, restores erectile function by downregulation of cavernous renin-angiotensin system in streptozocin-induced diabetic rats. J Sex Med. 2009 Mar; 6(3): 696-707. Epub 2008 Oct 20.
Haefeli WE, Linder L, Luscher TF. Qunaprilat induces arterial vasodilation mediated by nitric oxide in human. Hypertension. 1997; 30: 912-7.
Hornig B, Arakawa N, Drexler H. Effect of ACE inhibition on endothelial dysfunction in patients with chronic heart failure. Eur Heart J. 1998; 19: G48-G53.
Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart. 2003; 89: 251-4.
Chew KK, Earle CM, Stuckey BGA. Erectile dysfunction in general medicine practice: Prevalence and clinical correlates. Int J Impot Res. 2000; 12: 41-5.
Rosen RC, Cappelleri JC, Smith MD. Development and evaluation of the International Index of Erectile Function (IIEF-5) as diagnostic tool for erectile dysfunction. Int J Impot Res. 1999; 11: 319-26.
Toblli JE, Stella I, Inserra F. Morphological changes in cavernous tissue in spontaneously hypertensive rats. Am J Hypertens. 2000; 13: 686-92.
Jiang R, Chen JH, Jin J. Ultrastructural comparison of penile cavernous tissue between hypertensive and normotensive rats. Int J Impot Res. 2005; 17.
Speel TG, Kiemeney LA, Thien T, Smits P, Meuleman EJ. Long-term effect of inhibition of the angiotensin-converting enzyme (ACE) on cavernosal perfusion in men with atherosclerotic erectile dysfunction: A pilot study. J Sex Med. 2005 Mar; 2(2): 207-12.
Chew KK, Stuckey BGA, Thompson PL. Erectile dysfunction, sildenafil and cardiovascular risk. Med J Austral. 2000; 172: 279-83.
Felmand HA, Goldstein I, Hatzichristou DG. Construction of surrogate variable for impotence in the Massachusetts Male Aging Study. J Clin Epidemiol. 1994; 47: 457-67.
Shen ZJ, Jin XD, Chen ZD, Shi YH. Effect of aging on penile ultra structure. Asian J Androl. 2001; 4: 281-4.